Granules India (BOM:532482) 3-Year EPS without NRI Growth Rate : -8.80% (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Granules India 3-Year EPS without NRI Growth Rate?

Granules India's EPS without NRI for the three months ended in Mar. 2024 was ₹5.34.

During the past 12 months, Granules India's average EPS without NRI Growth Rate was -20.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was -8.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 20.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Granules India was 58.90% per year. The lowest was -8.80% per year. And the median was 24.50% per year.

Competitive Comparison of Granules India's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Granules India's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Granules India's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Granules India's 3-Year EPS without NRI Growth Rate falls into.

Granules India 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Granules India (BOM:532482) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Granules India 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Granules India's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Granules India (BOM:532482) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (BOM:532482) » Definitions » 3-Year EPS without NRI Growth Rate

Traded in Other Exchanges

GRANULES:India

Address

3rd Block, My Home Hub, 2nd Floor, Madhapur, Hyderabad, TG, IND, 500 081

Website

https://www.granulesindia.com

Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Granules India (BOM:532482) Headlines

No Headlines